River Brennan couldn't wait to start middle school, but after his lymphoma diagnosis, doctors said he would miss the entire ...

But overall, Blakely is handling it extremely well, and so are her parents. The Boyles have four children, ages 5, 4 (Blakely ...

Ethan Matera, a senior student-athlete at Conemaugh Township, has T-cell lymphoblastic lymphoma. He and his family are ...

WU-CART-007 has received Regenerative Medicine Advanced Therapy (RMAT), Fast Track, Orphan Drug, and Rare Pediatric Disease designations from the U.S. Food and Drug Administration and Priority ...

WU-CART-007 is an investigational anti-CD7 CAR-T cell therapy for relapsed or refractory T-ALL/LBL, derived from healthy donor T cells to avoid malignant contamination. The phase 2 trial aims to ...

-- First Pivotal Trial for an Off-the-Shelf, Allogeneic CD7-Targeted CAR-T Cell Therapy to Begin in First Quarter 2025 -- The Global Study Will Evaluate WU-CART-007 in Pediatric and Adult Patients ST.

Next-generation CAR T-cell therapies aim to improve accessibility, durability, and effectiveness, addressing current ...